Tag: Jeffrey Henderson October 15, 2026 $11 million grant to investigate why resident microbes go rogueWashU Medicine collaboration aims to uncover how gut bacteria turn dangerous.News Release January 25, 2022 Grossman, Henderson honored by international blood associationRecognized for research on convalescent plasma, COVID-19.National Leaders June 17, 2021 Blood cancer patients with COVID-19 fare better with convalescent plasmaRetrospective study also indicates outcomes of critically ill patients in ICU improve when given antibodies from recovered COVID-19 patients.News Release December 11, 2020 Infectious diseases organization honors 5 facultyBarrette, Henderson, Hunstad, Liang, Reno named fellows of Infectious Diseases Society of America.National Leaders May 8, 2020 On the front lines: Jeffrey HendersonInfectious diseases specialist describes how COVID-19 plasma therapy works.Video April 16, 2020 COVID-19 survivors needed to donate blood plasmaPlasma transfusion program launched at Washington University, Barnes-Jewish Hospital.News Release April 2, 2020 Podcast: Can plasma from COVID-19 survivors help others battle the disease?Henderson is a leader of clinical study exploring whether antibodies in plasma can be used as treatment.Podcast, Show Me the Science March 23, 2020 Possible COVID-19 treatment: transfusion of antibodies from recovered patients’ bloodCentury-old idea applied to modern pandemic.News Release August 12, 2019 Gut makeup could make diarrhea less likelyMolecular signature of a diarrhea-resistant gut found.News Release October 6, 2016 $2 million awarded to help prevent antibiotic resistanceFunding is part of $14 million awarded by CDC to curb growing threat.News Release July 13, 2015 Prone to UTIs? Try these simple dietary changesSource: NBC Today June 30, 2015 Your diet may be causing your urinary tract infectionsSource: Time Posts navigation